|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/44 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61K 38/18 | (2006.01) | ||
| A61K 9/00 | (2006.01) |
| (11) | Number of the document | 1725233 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05731600.2 |
| Date of filing the European patent application | 2005-03-14 | |
| (97) | Date of publication of the European application | 2006-11-29 |
| (45) | Date of publication and mention of the grant of the patent | 2011-01-05 |
| (46) | Date of publication of the claims translation | 2011-04-26 |
| (86) | Number | PCT/US2005/008346 |
| Date | 2005-03-14 |
| (87) | Number | WO 2005/089757 |
| Date | 2005-09-29 |
| (30) | Number | Date | Country code |
| 553578 P | 2004-03-15 | US |
| (72) |
HIGAKI, Masaru, JP
NAKAO Satoshi, JP
|
| (73) |
Sunesis Pharmaceuticals, Inc.,
395 Oyster Point Blvd., Suite 400, South San Francisco, CA 94080,
US
Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome Chuo-ku, Osaka-shi Osaka 541-8524, JP |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Farmacinė kompozicija, apimanti SNS-595, ir jos panaudojimo būdai |
| PHARMACEUTICAL COMPOSITION COMPRISING SNS-595 AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2018-02-23 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-03-14 |